2024 |
Seres Therapeutics Inc
|
Independent Director |
131.0 K |
- |
2024 |
Longeveron Inc - Ordinary Shares - Class A
|
Independent Director |
60.2 K |
- |
2024 |
Bicycle Therapeutics Plc - ADR
|
Independent Director |
- |
- |
2024 |
Omega Therapeutics Inc
|
Independent Director |
- |
- |
2023 |
Bicycle Therapeutics Plc - ADR
|
Independent Director |
526.9 K |
-32.0 % |
2023 |
Longeveron Inc - Ordinary Shares - Class A
|
Independent Director |
- |
- |
2022 |
Bicycle Therapeutics Plc - ADR
|
Independent Director |
775.3 K |
158.4 % |
2022 |
Seres Therapeutics Inc
|
Independent Director |
- |
- |
2021 |
Bicycle Therapeutics Plc - ADR
|
Independent Director |
300.0 K |
25.1 % |
2021 |
Seres Therapeutics Inc
|
Independent Director |
- |
- |
2020 |
Bicycle Therapeutics Plc - ADR
|
Independent Director |
239.9 K |
5.2 % |
2020 |
Seres Therapeutics Inc
|
Independent Director |
- |
- |
2019 |
Bicycle Therapeutics Plc - ADR
|
Independent Director |
228.0 K |
- |
2019 |
Seres Therapeutics Inc
|
Independent Director |
88.2 K |
-40.1 % |
2018 |
Seres Therapeutics Inc
|
Independent Director |
147.2 K |
-20.2 % |
2017 |
Seres Therapeutics Inc
|
Independent Director |
184.4 K |
-50.9 % |
2016 |
Seres Therapeutics Inc
|
Independent Director |
375.4 K |
70.0 % |
2015 |
Seres Therapeutics Inc
|
Independent Director |
220.9 K |
-45.8 % |
2014 |
Seres Therapeutics Inc
|
Independent Director |
407.3 K |
- |